Neuroprotective effect of pyruvate and oxaloacetate during pilocarpine induced status epilepticus in rats

Neurochem Int. 2011 Feb;58(3):385-90. doi: 10.1016/j.neuint.2010.12.014. Epub 2010 Dec 24.

Abstract

Recent research data have shown that systemic administration of pyruvate and oxaloacetate causes an increased brain-to-blood glutamate efflux. Since increased release of glutamate during epileptic seizures can lead to excitotoxicity and neuronal cell death, we tested the hypothesis that glutamate scavenging mediated by pyruvate and oxaloacetate systemic administration could have a neuroprotective effect in rats subjected to status epilepticus (SE). SE was induced by a single dose of pilocarpine (350mg/kgi.p.). Thirty minutes after SE onset, a single dose of pyruvate (250mg/kgi.p.), oxaloacetate (1.4mg/kgi.p.), or both substances was administrated. Acute neuronal loss in hippocampal regions CA1 and hilus was quantitatively determined five hours after SE onset, using the optical fractionator method for stereological cell counting. Apoptotic cascade in the hippocampus was also investigated seven days after SE using caspase-1 and -3 activity assays. SE-induced neuronal loss in CA1 was completely prevented in rats treated with pyruvate plus oxaloacetate. The SE-induced caspase-1 activation was significantly reduced when rats were treated with oxaloacetate or pyruvate plus oxaloacetate. The treatment with pyruvate and oxaloacetate caused a neuroprotective effect in rats subjected to pilocarpine-induced SE.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Disease Models, Animal
  • Male
  • Nerve Degeneration / drug therapy*
  • Nerve Degeneration / etiology
  • Neuroprotective Agents / pharmacology*
  • Oxaloacetic Acid / pharmacology*
  • Oxaloacetic Acid / therapeutic use
  • Pyruvic Acid / metabolism
  • Pyruvic Acid / pharmacology*
  • Rats
  • Rats, Wistar
  • Status Epilepticus / chemically induced
  • Status Epilepticus / complications
  • Status Epilepticus / prevention & control*

Substances

  • Neuroprotective Agents
  • Oxaloacetic Acid
  • Pyruvic Acid